Beta Bionics raised $60M in a Series E funding round led by Wellington Management to support the commercialization of the iLet bionic pancreas.
Amount Raised
$60 Million
Round Type
Series E
Investors
Description
Beta Bionics has closed a Series E preferred stock financing round worth a total of $60 million. The funding will support the expanded commercialization of its iLet bionic pancreas and product pipeline development.
Quick answer
Beta Bionics raised $60 Million in a Series E round, dated November 14, 2024. Investors: Marshall Wace, Perceptive Advisors, RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Eventide Asset Management, LLC and Wellington Management. Beta Bionics is based in Irvine, California, United States.
- How much did Beta Bionics raise?
- Beta Bionics raised $60 Million in a Series E round on November 14, 2024.
- Who invested in Beta Bionics?
- Marshall Wace, Perceptive Advisors, RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Eventide Asset Management, LLC and Wellington Management are named as investors in this round.
- What does Beta Bionics do?
- Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with..
- Where is Beta Bionics based and how big is it?
- Beta Bionics is based in Irvine, California, United States. Fundz records about 455 employees.
- Who are the decision-makers at Beta Bionics?
- Fundz holds 2 contacts at Beta Bionics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Beta Bionics that raised within 45 days of this round, from Fundz verified event records.
- Novel Microdevices raised $567K (Seed) on December 27, 2024.
- Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
- Anebulo Pharmaceuticals raised $15M on December 22, 2024.
- Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
- Alessa Therapeutics raised $15M (Seed) on December 19, 2024.
Who to call at Beta Bionics, and when
A new round usually means Beta Bionics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Beta Bionics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beta Bionics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beta Bionics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beta Bionics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Beta Bionics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.